Thyroid Diseases Have a Predictive Impact on the Clinical Severeity of Covid-19

Main Article Content

Dr. Ihtisham Ul Khaliq, Maria Karim, Dr. Maham Irfan, Bushra Tahreem, Umair Mudassar, Sajid Ullah, Izba Amjad, Irum Javed, Dr. Jawwad Muhammad Shujaat

Abstract

Objective: Aim of current study is to assess the diseases of the thyroid gland have a predictive effect on the clinical severity of COVID-19.


Study Design: The current Prospective Study was carried out in Khyber Medical University (KMU) from Jan 2021-November 2021.


Methods: One hundred and fifty patients of both genders were presented in this study. Ages of the patients were between 25-80 years. All patients provided informed written consent for the collection of detailed demographic information, including age, gender; body mass index, residency, educational status, and socio-economic status. All the patients were undergone for PCR test for the confirmation of pandemic disease. Patients were categorized into two equal groups, I and II. Seventy five (75) symptomatic patients were included in group I and group II had 75 asymptomatic cases. It was determined whether the subjects had thyroid-stimulating hormone (TSH), free thyroxine (FT4), free triiodothyronine (FT3), thyroid peroxidase antibody, or thyroglobulin antibody in their blood. We used SPSS 22.0 edition to analyze complete data.


Results: Ninety (90) patients (45 in each group) were males and the rest 60 patients were females. 51.32 ± 4.19 years was the mean age in group I with mean body mass index26.13±13.23 kg/m2 and in group II mean age was 49.45±23.77 years with mean BMI 25.11±9.44 kg/m2. 32 (42.7%) and 35 (46.7%) cases had urban residency in group I and II respectively. 29 (38.9%) patients were literate in group I and in group II 33 (44%) cases were educated. Majority of the patients among both groups had poor socio-economic status 52 (69.3%) in I and 49 (65.3%) in II. In group I majority of the patients 43 (57.3%) cases had severity of disease and in group II 18 (24%) patients had severe infection. Comparing the results of group I patients to those of group II, it was found that group I patients had considerably lower blood levels of free thyroxine (FT4) as well as blood levels of free triiodothyronine (FT3). Frequency of overt thyroid disorder was significantly higher in group I found in 9 (12%) as compared to group II 4 (5.3%). We found 18 (24%) cases in group I had thyroid nodules size>1cm while in group II 8 (10.7%) had nodule size >1cm. Mortality in group I was significantly higher with p value <0.05.


Conclusion: This study came to the conclusion that overt thyroid hormonal abnormalities were more prevalent in severely ill COVID-19 patients. It is possible that the FT3 level at the time of hospital admission is a prognostic indicator in COVID-19 patients. Symptoms of severe COVID-19 disease may include thyroid nodules.

Article Details

How to Cite
Dr. Ihtisham Ul Khaliq, Maria Karim, Dr. Maham Irfan, Bushra Tahreem, Umair Mudassar, Sajid Ullah, Izba Amjad, Irum Javed, Dr. Jawwad Muhammad Shujaat. (2022). Thyroid Diseases Have a Predictive Impact on the Clinical Severeity of Covid-19. Annals of the Romanian Society for Cell Biology, 26(01), 87–94. Retrieved from https://annalsofrscb.ro/index.php/journal/article/view/10680
Section
Articles